Responsible for conducting antimicrobial assessments of skin antiseptics and surface disinfectant formulations and technologies for use in healthcare and food service settings.•Established an in-house microbiology laboratory capable of testing PDI products that includes antiseptics (NDA and OTC) and EPA regulated disinfectants in both non-woven and spray formats.•Managed junior Scientists to enable them to reach their full potential.•Developed the capability to test Clostridium difficile via the EPA germicidal carrier test thereby reducing costs.•Developed new policy for evaluating products for preservative efficacy based upon product category and compendia methodology to streamline the product development process.•Conducted in vitro and in vivo clinical testing for submission to FDA for NDA antiseptics as well as 510K medical device submissions resulting in the launch of new antiseptic/disinfectant productsDeveloped and reviewed IRB submission, protocols, and final reportsEnsured Clinical samples were processed in compliance with GCPsWrote research reports based upon data generated from these studiesMonitored Clinical studiesMaintained study files for submission to FDA and EPA •Liaison for external testing thereby eliminating duplicate efforts from other internal groups.Wrote and reviewed protocolsEnsured compliance with protocols by monitoring study sites Reviewed dataWrote summary reports based upon data•Biofilm strategy- ensured compliance with EPA regulations as well as developed a research strategy for further claims consideration in order to develop products to kill biofilm in hospital, food preparation, and household settings.•Microbial content and identity- Ensured raw materials and finished goods were compliant with microbiological specifications. according to FDA regulations.Identified microorganisms to species using Vitek and Biolog systems as well as classical microbiological techniques.

Directed OTC product development using external laboratories and contract manufacturers for iconic brands including Chloraseptic®, Compound W®, New Skin®, Percogesic®, Dermoplast®, and Little Remedies®.• Developed OTC formulations: Chloraseptic® lozenges, strips, and sore throat sprays.• Reformulated New Skin® Liquid bandage to comply with OTC monographs for antiseptic products.• Expanded the Little Remedies® line of products resulting in a more extensive portfolio of OTC and cosmetic products to treat childhood diseases and symptoms.• Collaborated with Marketing to expand the Little Remedies® line growing the brand in a shrinking economy.• Evaluated new technologies for business development and acquisition opportunities.• Negotiated development agreements and pricing with external resources reducing overall development costs by $500 Million.• Constructed and maintained project timelines to ensure on time delivery of products.•Solved manufacturing problems to successfully meet product demand and streamline operations.

Managed a group of three Scientists and two Lab Techs that provided microbiological support for all of Pfizer’s Oral Care Product Development projects.• Developed unique microbiological manual and robotic methods that assessed antimicrobial properties of novel oral care treatments against biofilm and planktonic microbiota resulting in 50% faster delivery time and 100% increase in samples evaluated.•Conducted the internal and external clinical studies which included Kill Kinetics and Minimum Inhibitory Concentration (MIC/MBC) assays to support the in vitro antimicrobial claims of Freshburst Listerine®, Tartar Control Listerine®, and Citrus Listerine® resulting in the granting of the American Dental Association Seal of Acceptance for plaque and gingivitis.• Supported the advertising claims of freshening breath by killing malodorogenic microorganisms for Listerine® Pocket Packs (Coolmint, Freshburst, and Citrus) by developing the protocols and conducting the internal and external clinical studies.

Conducted the antimicrobial assays used to support all Listerine® branded products and for developing unique assays to evaluate the anticalculus efficacy of Tartar Control Listerine®.• Designed assay showing tensile strength reduction of zinc chloride treated in vitro grown calculus.• Developed assays to show zinc chloride treated calculus crystal growth morphology changes.• Performed pH stat assay to evaluate crystal nucleation delay with zinc chloride.• Investigated zinc chloride binding to hydroxyappatite in an in vitro model of my design.• Supported product launch and advertising claims resulting in annual sales of $40 Million.

Performed compendia microbiological assays for the analysis of OTC and confectionary products.• Executed Antimicrobial Effectiveness (preservative challenge) from both US and British pharmacopoeia.• Analyzed foods and confections for microbial content using methods described in the F.D.A.’s Bacteria Analytical Manual.• Conducted microbiological based water analysis as described by the APHA.• Audited manufacturing facilities and associated microbiology laboratories.• Established HACCP plans for manufacturing facilities.• Implemented cleaning validation studies at contract manufacturing sites.• Wrote Standard Operating Procedures (SOPs) and Work Instructions for microbiology laboratories using information mapping.

Product Development for Chewing Gums and Confections.• Formulated bubble gums using new soft chew gum base technology.